Prospective Sinonasal Cancer Multi-institution Study

Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Inclusion Criteria:

• Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
• Patients with a diagnosis of sinonasal cancer
• Patients undergoing treatment at Mayo Clinic

Exclusion Criteria:

• Healthy individuals
• Unwilling to sign the informed consent